On May 25, with Gov. Greg Abbott’s signing of Senate Bill 680, Texas became the fourth state this year to increase protection for patients subject to insurers’ step therapy protocols. The State of Texas Association of Rheumatologists (STAR) joined with 35 other professional societies and patient advocacy organizations in urging passage of S.B. 680. The…
Gretchen Henkel is an award-winning health and medical journalist based in California. She reports on clinical and outcomes research and practice management issues, as well as patient-centered and culturally competent care for various specialties, including hospital medicine, rheumatology, oncology, otolaryngology and long-term care. As an editorial consultant for the SAMHSA-funded National Child Traumatic Stress Network, she develops content for toolkits on assessment and treatment of childhood abuse and trauma, and is the managing editor of the NCTSN quarterly newsletter, IMPACT.
Articles by Gretchen Henkel
S.C. Rheumatism Society Benefits from ACR Partnership
Editor’s note: This article will be the first in a series of articles highlighting the advocacy work done by state and local societies around the country. The South Carolina Rheumatism Society (SCRS) realizes multiple benefits from its association with the ACR, according to Jeffrey G. Lawson, MD, the society’s treasurer. One example of the support offered:…
NYU Langone’s Division of Rheumatology in Manhattan Advances Its Mission to Understand Rheumatic Diseases, Improve Patient Outcomes
From its beginnings as the Rheumatic Diseases Study Group (RDSG) in the early 1930s, NYU Langone Medical Center’s Division of Rheumatology has been built on a tradition of research and clinical care. Today’s division, with 24 full-time and 76 part-time faculty members, continues to push toward understanding the pathogenesis of rheumatic diseases and interventions to…
University of Alabama at Birmingham’s Division of Clinical Immunology & Rheumatology Recognized for Excellence
An interdisciplinary and collaborative environment is a critical factor for the advancement of basic science and clinical research in the academic environment, says William J. Koopman, MD, former director of the University of Alabama at Birmingham’s (UAB’s) Division of Clinical Immunology and Rheumatology. And in 1977, when he was being recruited by Division Director J….
Rheumatologists Remember Dr. Engleman, Pioneer, Leader, ‘Full Human Being’
Two years ago, at the age of 102, rheumatologist Ephraim P. Engleman, MD, FACR, FACP, published a memoir, My Century, in which he detailed his personal and professional accomplishments, as well as his secrets to longevity. With his characteristic sense of humor, Dr. Engleman noted that the first secret to a long life is to…
Interdisciplinary Collaboration at Wash U Advances Understanding of Immunology, Rheumatology
In June 2014, 10 members of a church group returned to St. Louis from Haiti, where they had contracted chikungunya virus (CHIKV), a mosquito-transmitted alphavirus previously unknown in the Western hemisphere that produces inflammatory arthritis symptoms. Because CHIKV-related arthritis mimics seronegative RA, a group of clinicians, immunologists, virologists and geneticists at the Washington University in…
Dual-Trained Rheumatologists Take Multidisciplinary Approach to Their Patients
Co-morbidities in patients with rheumatoid arthritis and related autoimmune diseases often warrant a multidisciplinary approach to treatment. When it comes to inflammatory and fibrotic lung conditions in these patients, collaboration between pulmonary/critical care specialists and rheumatologists is essential, say two rheumatologists recently interviewed by The Rheumatologist. Both followed their rheumatology fellowship training with additional fellowships…
Patient’s Journey with Rheumatoid Arthritis Redefines ‘Treat to Target’
Rheumatologist Richard Brasington, MD, says patient John Reigstad’s active participation in treatment decisions shows how much improving quality of life matters
NIAMS’ Intramural Research Programs Foster Spirit of Discovery
National Institute of Arthritis and Musculoskeletal and Skin Diseases program recognized for excellence in training, innovation
Glucocorticoid Use in Rheumatoid Arthritis Management Focus of Ongoing Debate
Questions around prescribing steroids as bridge therapy, in long-term low dosages, or low-dose timed-release formulas, or not at all evoke controversy among rheumatologists
- « Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- …
- 12
- Next Page »